Alerts

Further examples of counterfeit Ozempic-labelled products have been detected and stopped at the Australian border.

Caruso's Natural Health Pty Ltd is recalling certain batches of WEE LESS, BLOAT EZE and ASHWAGANDHA 7500 due to suspected tampering.

The oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be given to children under 6 years of age.

We have become aware of an increasing number of cases of liver injury reported in scientific literature, by consumers who had taken products containing Garcinia gummi-gutta.

The TGA has received reports of serious adverse events in infants and children who have been given compounded wind and colic preparations containing Atropa belladonna (belladonna).

Sun Herbal Pty Ltd is recalling Clear the Skin Formula a.k.a. Liang Xue Xiao Feng San CM116, a Chinese medicine for skin rash because the label does not display the required warning statement.

Read our safety advisory for Medicines containing Withania somnifera (Withania, Ashwagandha). Be aware of potential gastrointestinal symptoms and very rare cases of liver injury.

Sub Herbal is recalling all batches supplied in Australia of Liu Wei Di Huang Wan (Rehmannia Six Formula) supplements as a precaution. There is potential for the medicine to result in unacceptable amounts of lead.

Kin Fertility Pty Ltd is recalling several batches of The Prenatal capsules due to reported quality problems with the capsules. There is no indication of any safety concerns.

If you've purchased APOHEALTH Paracetamol Pain Relief paracetamol 500 mg film-coated tablets in a bottle, ensure it is kept out of reach of children. This product does not have child-resistant packaging.

The TGA has received reports of liver problems experienced by consumers taking medicines containing turmeric or curcumin.

BioCeuticals is recalling one Batch 220380 (exp 02/2024) of Ultra Potent-C Chewable (60s) (AUST L 208690) following a consumer report of a metal fragment found in one tablet.

The TGA has decided to cancel the registration of pholcodine-containing medicines and is recalling them from pharmacies.

Human albumin (all alerts)

Update 2 - contamination with N-nitrosodimethylamine

On 21 March 2012, the TGA agreed that the release procedure involving TGA's batch-by-batch review of CSL's ethylene glycol test results need not apply to batches of albumin solution manufactured after 25 January 2012.

Quarantine of some CSL Biotherapies batches of human albumin product (ALBUMEX) pending further analysis

CSL Biotherapies notified the TGA on 7 March 2012 that some batches of human albumin solutions manufactured prior to 25 January 2012 have been contaminated with ethylene glycol as a consequence of an equipment failure.

The Therapeutic Goods Administration (TGA) has taken steps today to quarantine CSL Human Albumin solutions from further use while an assessment is undertaken of the safety of these products.

Human albumin: Clinical advice on ethylene glycol

About Octagam 5%: lifting of the voluntary recall

The Therapeutic Goods Administration (TGA) advises that Octapharma Australia Pty Ltd has agreed to a precautionary voluntary recall of all batches of Octagam intravenous immunoglobulin solutions from the Australian market.